<p>Cells were treated with different concentrations of exemestane after 3, 6 and 9 days. Cells with 50 µM of zVAD or with 1 mM of 3-MA, with or without exemestane (5–15 µM), were also studied for 3 and 6 days, respectively. Treated cells were harvested, stained with acridine orange and analyzed by flow cytometry. Data are presented as single cell events of viable cells, AO negative (AO<sup>−</sup>), and with AVO formation, AO positive (AO<sup>+</sup>). Cells cultured with T were considered as control and cells treated with T and H<sub>2</sub>O<sub>2</sub> (0.05 mM) were considered as positive control for autophagic cell death. The data represents means ± SEM of three independent experiments done in triplicate. The ratio treatment/control is...
Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormo...
<p>Here, cells without any treatment were used as the untreated control (CTL). All experiments were...
Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormo...
<p>Cells were treated with different concentrations of exemestane for 6 and 9 days. Treated cells we...
<p>To study cell viability (A, B) and cell proliferation (C), cells were treated with different conc...
<p>Cells were pretreated with 5 mmol/L 3-MA for 1 h before exposure to 10 µmol/L 5-FU for 48 h, then...
<p>(A) Annexin V-PE labelling of MCF-7aro cells treated with exemestane (15 µM) for 6 and 9 days of ...
<p>AVOs formation is associated with the establishment of an autophagic process. Prolonged treatment...
<p>(A) Microphotograph of AVOs in LNCaP and PC-3 cells. Detection of green and red fluorescence in a...
<p>(A) Early apoptosis, detected using an Annexin V apoptosis detection kit, was measured using flow...
<p>(A) A representative flow cytometric dot plots showing the increase in the AVOs percentage in HeL...
<p>Caspase-9 (A), caspase-8 (B) and caspase-7 (C) activities of MCF-7aro cells treated with exemesta...
<p>HCM and HUVE cells treated with 5-FU at the indicated concentrations together with the ROS scaven...
<p>(A) Ultrastructural observations in SGC-7901 cells with transmission electron microscope. (a) Unt...
<p>(A) JC-1 assay for detection of the mitochondrial membrane potential at 24 h of TG or TM treatmen...
Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormo...
<p>Here, cells without any treatment were used as the untreated control (CTL). All experiments were...
Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormo...
<p>Cells were treated with different concentrations of exemestane for 6 and 9 days. Treated cells we...
<p>To study cell viability (A, B) and cell proliferation (C), cells were treated with different conc...
<p>Cells were pretreated with 5 mmol/L 3-MA for 1 h before exposure to 10 µmol/L 5-FU for 48 h, then...
<p>(A) Annexin V-PE labelling of MCF-7aro cells treated with exemestane (15 µM) for 6 and 9 days of ...
<p>AVOs formation is associated with the establishment of an autophagic process. Prolonged treatment...
<p>(A) Microphotograph of AVOs in LNCaP and PC-3 cells. Detection of green and red fluorescence in a...
<p>(A) Early apoptosis, detected using an Annexin V apoptosis detection kit, was measured using flow...
<p>(A) A representative flow cytometric dot plots showing the increase in the AVOs percentage in HeL...
<p>Caspase-9 (A), caspase-8 (B) and caspase-7 (C) activities of MCF-7aro cells treated with exemesta...
<p>HCM and HUVE cells treated with 5-FU at the indicated concentrations together with the ROS scaven...
<p>(A) Ultrastructural observations in SGC-7901 cells with transmission electron microscope. (a) Unt...
<p>(A) JC-1 assay for detection of the mitochondrial membrane potential at 24 h of TG or TM treatmen...
Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormo...
<p>Here, cells without any treatment were used as the untreated control (CTL). All experiments were...
Aromatase inhibitors (AIs), which block the conversion of androgens to estrogens, are used for hormo...